QA: Pacira BioSciences Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001396814_2020_Pacira_BioSciences_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 421026000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001396814, Pacira BioSciences Inc.

  xvar xval
0 AssetsCurrent 408,557,000
1 IntangibleAssetsNetIncludingGoodwill 203,934,000
2 PropertyPlantAndEquipmentNet 104,681,000
3 remainder_Assets 113,893,000
4 LiabilitiesCurrent 107,673,000
5 LiabilitiesNoncurrent 42,440,000
6 remainder_Liabilities 326,008,000
7 CostOfGoodsAndServicesSold 106,712,000
8 SellingGeneralAndAdministrativeExpense 200,782,000
9 ResearchAndDevelopmentExpense 72,119,000
10 remainder_Expenses 31,201,000
11 remainder_Revenues 421,026,000
12 remainder_NetIncome -21,228,000
13 remainder_ComprehensiveNetIncome 602,000
  yvar yval
0 Assets 831,065,000
1 Liabilities 476,121,000
2 Expenses 410,814,000
3 Revenues 421,026,000
4 StockholdersEquity 354,944,000
5 NetIncome -11,016,000
6 ComprehensiveNetIncome -10,715,000
7 BaseVar 1,080,428,000
8 EconomicCapitalRatio 0.918

Edgar->Model Mapping

Feature Distribution

Change over Time